Ovarian Reserve Better Indicator of Adjuvant Chemotherapy Benefit than Self-Reported Menopause Status, Age, or Other Hormone Levels By Ogkologos - August 4, 2026 154 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the RxPONDER study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Study Shows That Fast-Mimicking Diets Are Safe and Effective for Patients... July 20, 2020 Satisfying Snacks November 13, 2020 BREAKING: President Trump May Restore The WHO’s Funding, With Some Conditions May 18, 2020 FDA Approves Daratumumab and Hyaluronidase-fihj with Bortezomib, Lenalidomide, and Dexamethasone for... February 11, 2026 Load more HOT NEWS Lorlatinib Continues to Show Long-Term Benefit in Newly-Diagnosed Patients with Advanced... EMA Recommends Granting a Conditional Marketing Authorisation for Idecabtagene Vicleucel Cancer in My Community: Improving Access to Palliative Care in Indonesia Beloved Kansas City Jazz Singer Passes Away at 48 After 13-Year...
